On Wednesday, October 9, from 6-9 p.m., Americans for Free Choice In Medicine (AFCM) will present a panel discussion on the consequences of the FDA's further encroachment on patients' rights and policy changes that can restore the ability of patients to choose innovative, life-saving treatments, and protect the rights of physicians to perform them, according to a press release.
This event is co-sponsored by the Association of American Physicians and Surgeons (AAPS) and will feature a patient advocate, physician and two health care policy experts. The discussion will take place at the National Press Club in Washington, D.C., with a video of the event streaming live at FDAvPatients.com and an archived video available at the same site the following day.
Americans for Free Choice In Medicine has been promoting the rights of individuals since 1993. Richard E. Ralston, Executive Director of AFCM, wrote the following in an article titled Asking the Government for Permission to Live:
The Food and Drug Administration (FDA) has gone to court to prevent the Colorado-based firm Regenerative Sciences from using stem cells developed in one part of your body (bone marrow) to repair damage in other parts of your body, such as joints. The FDA objects to the fact that these cells are chemicals, the use of which they have the power to regulate even though the cells are taken from your body to later be injected back into your body.
Ralston also wrote about The Independent Payment Advisory Board appointed by the President. This Board decides whether it will allow payment for any care, including the use of a person's own stem cells. If a person is on Medicare and his physician accepts Medicare patients, the person may not even use his own money for treatment with his own stem cells. No physician in Medicare is allowed to accept payment for anything not covered by Medicare.
In a different article by Ralston, it was said that the FDA issued a warning about the use of venal catheters as a result of a physician conducting a clinical trial for treatment of multiple sclerosis. After approving the safety and efficacy of the device, the FDA is demanding that it approve every use by individual physicians.
The FDA has a record of approving and/or allowing dangerous chemicals to infiltrate the foods that Americans consume, yet so burden the system of health care that terminal patients die while awaiting the approval of medicines.
A close look at the connections and ties between the FDA and big business suggests a pay-to-play relationship.
For some diseases and chronic syndromes, the only holistic medicine available to an individual is the use of his own stem cells within his own body. Apparently, the FDA is assuming control over the stem cells, which the FDA refers to as chemicals, that belong to the individual by reason of common sense. Although, it has been proven that the FDA neither has or uses the common sense of others.